Fox Chase Cancer Center News

PHILADELPHIA (April 23, 2021) — Fox Chase Cancer Center is pleased to announce its ongoing support for the annual Sandy Rollman Ovarian Cancer Foundation’s Sandy Sprint the World virtual 5k &10k run/walk. Due to COVID-19 precautions, instead of the event being one day, faculty, staff, volunteers, patients, survivors, and their families can compete from April 24 through May 8.

PHILADELPHIA (April 22, 2021)—The use of molecular profiling to identify the molecular and genetic signatures of cancer and deliver highly specific treatments was named the top advance of the year in the treatment of cancer, according to a recent collaborative report from the American Society of Clinical Oncology (ASCO).

PHILADELPHIA (April 22, 2021)—Alexander Kutikov, MD, FACS, chief of the Division of Urology and Urologic Oncology at Fox Chase Cancer Center, was recognized by the American Urological Association (AUA) as the winner of the Young Urologist of the Year Award for the Mid-Atlantic Section.

PHILADELPHIA (April 21, 2021)—Researchers at Fox Chase Cancer have published a study investigating the safety and efficacy of a vaccine, given alone and in combination with a PD-1 checkpoint inhibitor, that may prevent colon cancer in certain populations. In a preclinical in vivo model, when administered to mice predisposed to develop colon cancer, the vaccine primed their immune systems to recognize and fight cancer cells and prevent tumors from forming.

PHILADELPHIA (April 19, 2021) – The Pennsylvania Medical Society (PAMED) released its list of the 2021 Top Physicians Under 40. Six Fox Chase Cancer Center doctors were honored:

PHILADELPHIA (April 16, 2021)—Alexander Kutikov, MD, FACS, chief of the Division of Urology and Urologic Oncology at Fox Chase Cancer Center, co-authored two publications examining important treatment decisions in kidney cancer and illustrating the role of minimally invasive partial nephrectomy—partial removal of the kidney—in the treatment of renal masses, which are abnormal growths on the kidney.

PHILADELPHIA (April 16, 2021)—Colleen H. Tetzlaff, MHS, PA-C, advanced practice clinician in the Department of Hematology/Oncology at Fox Chase Cancer Center, has been recognized as the recipient of the first-ever Sharon Schwartz Award, which is presented by the Recognition and Development Model (RDM) Committee at Fox Chase.

PHILADELPHIA (April 14, 2021) – In a study published today, researchers at Fox Chase Cancer Center announced that they have discovered a novel approach to triggering a type of cancer cell death called ferroptosis that could have therapeutic potential.